Silent Theatre presentations

Programme stream(s): Silent theatre
Programme session type(s): No session type

12:40-13:55

Room: Silent theatre 2 - Hall 4

These theatres provide an area for accepted abstract submitters to present their research in 5 minute presentations.

The abstract presentations in this session are:

12.40 – Ogechi Nkeonye, Disulfiram reverses chemoresistance in pancreatic ductal adenocarcinoma (PDAC) by targeting hypoxia induced NF-KB pathway to eradicate cancer stem cell population

12.46 – Karim Azar, Disulfiram Inhibits NF-kappaB Pathway And Targets Glioblastoma Stem Cells

12.52 – Maria Martinez, Hospital admissions with Immunotherapy toxicities in melanoma patients on Ipilimumab and Nivolumab

12.58 – Rose Gray, Improving treatment and care for older people with cancer

13.04 – Milan Vu, Betulinic acid-doxorubicin drug combination synergistically supresses cell viability and enhances apoptotic death in acute myeloid leukaemia cell lines by increasing Bax/Bcl-2 ratio

13.10 – Noor Hasan, The combination of curcumin and doxorubicin shows a selective cytotoxic effect on acute myeloid leukaemia cell line

13.16 – Amit Goyal, POSNOC – Positive Sentinel Node: Adjuvant therapy alone versus adjuvant therapy plus clearance or axillary radiotherapy (ISRCTN54765244, Clinicaltrials.gov NCT02401685)

13.22 – Ivan Salarić, Salivary melatonin and squamous cell carcinoma antigen 1 levels in patients with oral squamous cell carcinoma

13.28 – Louis Fox, Changes in physical activity and quality of life in men with prostate cancer participating in a physical activity behaviour change pathway

13.34 – George Morrissey, An Effective Pipeline for Whole Genome Sequencing for Research in a Tertiary Cancer Centre

13.40 – Rebecca Richmond, Investigating causal relationships between sleep characteristics and risk of breast cancer: a Mendelian randomization study

13.46 – Amanda Swan, Bevacizumab in the treatment of platinum resistant ovarian cancer at the Edinburgh Cancer Centre (ECC)